Delivering Answers to Pressing Questions About Cancer

Have cancer-related questions? CURE Educated Patient Summits are a great way to present these questions to experts in the field.

At CURE, we remain steadfastly dedicated to providing our readers with answers.

CURE’s Educated Patient Summits, held throughout the year, offer both the chance to hear experts discuss the big issues at the heart of this field and the opportunity to present questions to some of those experts.

One example of the latter can be found in this seasonal issue of CURE, as we speak with Dr. Jyoti Malhotra, director of thoracic medical oncology at City of Hope Orange County, in California, and a presenter at the Educated Patient Lung Cancer Summit, to get answers to 10 of the most commonly asked patient questions in the lung cancer space.

You’ll find Malhotra’s insights on treatment options, monitoring and more.

Elsewhere, you will hear from a member of our advisory board — Dr. Michael K. Wong, physician in chief at the Roswell Park Comprehensive Cancer Center in Buffalo, New York — who has some helpful and actionable advice on how patients can get the most out of the online portals used to communicate with their care team.

Additionally, we report on advancements in the field of antibody-drug conjugates and speak with two patients with breast cancer who have benefited from these treatments.

“After two failed clinical trials, I experienced severe despair, but I have gained hope through this new drug,” one patient, Hyunji Kim, said. “The previous trials had significant side effects … but this new medication has been much easier to tolerate, with only slight appetite loss and fatigue. If there are other patients in a similar situation, I would strongly recommend it.”

For all of the up-to-the-minute oncology updates, be sure to stay tuned to curetoday.com. There, you will find everything from breaking news on the latest FDA approvals to expert context on major cancer news and much more.

Throughout these pages, you’ll find personal stories and expert insights. As always, we hope you find them inspirational and informative. Thank you for reading.

Mike Hennessy Jr.
President and CEO
MJH Life Sciences

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.